Ha guidato il primo intervento chirurgico endoscopico transfenoidale presso il Bangkok Hospital Chanthaburi – una svolta minimamente invasiva per le condizioni spinali.
Board-certified physiatrist (Diplomate of the Thai Board of Rehabilitation Medicine, 2023). Head of Rehabilitation at King Mongkut Chaokhunthahan Hospital. CEO and Founder of PYONG Rehabilitation Group since 2023.
Clinical focus: neurorehabilitation, geriatric rehabilitation, and chronic pain. Uses robotics and wearable exoskeleton gait training. Performs ultrasound-guided procedures and advanced laser and radiofrequency therapies.
Principal Investigator of a pilot randomized controlled trial on wearable exoskeleton gait training in subacute stroke. Presented to the Royal College of Physiatrists of Thailand in 2023. Instructor at KMITL since 2020.
Completed Rehabilitation Medicine residency at Chulalongkorn University in 2023. Earned an MD in 2017. Runs a public health platform with over 100,000 followers. Hosted PYONG SUMMIT in 2024 with over 200 attendees. Honors include nominee for Quality Person of the Year 2025 and First Prize in the Ananda Mahidol Pin Design in 2016.
Dr. Ornicha Thititagul (Dr. Faangkaow) is a geriatrician and lecturer in the Geriatric Medicine Division at Siriraj Hospital, Mahidol University. She practices at Siriraj Samut Sakhon Geriatric Healthcare Center and Siriraj Piyamaharajkarun Hospital.
Accreditations include: M.D. (Second Class Honors, 2017); Diplomate, Thai Board of Internal Medicine (2021); WHO‑SEARO ICOPE Master Trainer (2021). Additional credentials: Diplomate in Geriatric Medicine (2023); Diplomate, International Board of Lifestyle Medicine (2024).
Research highlights include: a randomized controlled trial on oral nutritional supplements in older adults (Geriatrics, 2024); PG‑SGA versus MNA in hepatocellular carcinoma (Support Care Cancer 33, 116, 2025); and Thailand’s first abacavir hypersensitivity case report (J Med Assoc Thai, 2021). She was on the host team and served as a moderator at the 10th Asian Conference of Frailty and Sarcopenia in 2024.